Cargando…

Disease modifying effect of adiponectin in model of α-synucleinopathies

OBJECTIVE: Growing evidence suggests that neurodegenerative diseases are associated with metabolic disorders, but the mechanisms are still unclear. Better comprehension of this issue might provide a new strategy for treatment of neurodegenerative diseases. We investigated possible roles of adiponect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sekiyama, Kazunari, Waragai, Masaaki, Akatsu, Hiroyasu, Sugama, Shuei, Takenouchi, Takato, Takamatsu, Yoshiki, Fujita, Masayo, Sekigawa, Akio, Rockenstein, Edward, Inoue, Satoshi, La Spada, Albert R, Masliah, Eliezer, Hashimoto, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128281/ https://www.ncbi.nlm.nih.gov/pubmed/25126588 http://dx.doi.org/10.1002/acn3.77

Ejemplares similares

Diversity of Mitochondrial Pathology in a Mouse Model of Axonal Degeneration in Synucleinopathies
por: Sekigawa, Akio, et al.
Publicado: (2013)

Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies
por: Sekiyama, Kazunari, et al.
Publicado: (2012)

Importance of adiponectin activity in the pathogenesis of Alzheimer's disease
por: Waragai, Masaaki, et al.
Publicado: (2017)

A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain
por: Fujita, Masayo, et al.
Publicado: (2010)

Adiponectin Paradox as a Therapeutic Target in Alzheimer’s Disease
por: Waragai, Masaaki, et al.
Publicado: (2020)

Adiponectin Paradox in Alzheimer's Disease; Relevance to Amyloidogenic Evolvability?
por: Waragai, Masaaki, et al.
Publicado: (2020)

Motor and Nonmotor Symptoms of Parkinson's Disease: Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability?
por: Takamatsu, Yoshiki, et al.
Publicado: (2018)

Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies
por: Fujita, Masayo, et al.
Publicado: (2012)

Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer’s Disease
por: Hashimoto, Makoto, et al.
Publicado: (2021)

Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H ß-synuclein
por: Sekigawa, Akio, et al.
Publicado: (2012)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease
por: Waragai, Masaaki, et al.
Publicado: (2010)

Evolvability of Amyloidogenic Proteins in Human Brain
por: Hashimoto, Makoto, et al.
Publicado: (2018)

Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates
por: Hashimoto, Makoto, et al.
Publicado: (2018)

Possible Role of the Polyglutamine Elongation in Evolution of Amyloid-Related Evolvability
por: Hashimoto, Makoto, et al.
Publicado: (2018)

Transgenerational Interaction of Alzheimer’s Disease with Schizophrenia through Amyloid Evolvability
por: Takamatsu, Yoshiki, et al.
Publicado: (2019)

Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability
por: Hashimoto, Makoto, et al.
Publicado: (2020)

Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease
por: Hashimoto, Makoto, et al.
Publicado: (2019)

Connecting Alzheimer’s Disease With Diabetes Mellitus Through Amyloidogenic Evolvability
por: Ho, Gilbert, et al.
Publicado: (2020)

Combined immunotherapy with “anti-insulin resistance” therapy as a novel therapeutic strategy against neurodegenerative diseases
por: Takamatsu, Yoshiki, et al.
Publicado: (2017)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
por: Sekigawa, Akio, et al.
Publicado: (2015)

Bridging Molecular Genetics and Biomarkers in Lewy Body and Related Disorders
por: Ho, Gilbert J., et al.
Publicado: (2011)

Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
por: Ho, Gilbert, et al.
Publicado: (2021)

Stress-induced microglial activation occurs through β-adrenergic receptor: noradrenaline as a key neurotransmitter in microglial activation
por: Sugama, Shuei, et al.
Publicado: (2019)

Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease
por: Wei, Jianshe, et al.
Publicado: (2021)

Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy
por: Crews, Leslie, et al.
Publicado: (2010)

Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies
por: Kwon, Somin, et al.
Publicado: (2019)

Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson’s disease
por: Desplats, Paula, et al.
Publicado: (2012)

Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
por: Fares, Mohamed Bilal, et al.
Publicado: (2023)

Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
por: Kim, Changyoun, et al.
Publicado: (2018)

Differential Effects of UCHL1 Modulation on Alpha-Synuclein in PD-Like Models of Alpha-Synucleinopathy
por: Cartier, Anna E., et al.
Publicado: (2012)

Reconsideration of Alzheimer’s Disease Therapy from a Viewpoint of Amyloidogenic Evolvability
por: Ho, Gilbert, et al.
Publicado: (2022)

Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson's Disease
por: Wei, Jianshe, et al.
Publicado: (2021)

Alterations in mGluR5 Expression and Signaling in Lewy Body Disease and in Transgenic Models of Alpha-Synucleinopathy – Implications for Excitotoxicity
por: Price, Diana L., et al.
Publicado: (2010)

Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy
por: Spencer, Brian, et al.
Publicado: (2017)

NEDD4-mediated HSF1 degradation underlies α-synucleinopathy
por: Kim, Eunhee, et al.
Publicado: (2016)

Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease
por: Kaul, Tiffany, et al.
Publicado: (2011)

APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis
por: Crews, Leslie, et al.
Publicado: (2009)

Oligodendroglial α‐synucleinopathy‐driven neuroinflammation in multiple system atrophy
por: Hoffmann, Alana, et al.
Publicado: (2019)

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
por: Duka, Valeriy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pat7amed2t4j0m5drfou61onmj